Skip to content

A randomized controlled study of transumbilical and transvaginal single hole laparoscopy in the removal of ovarian teratoma

A randomized controlled study of transumbilical and transvaginal single hole laparoscopy in the removal of ovarian teratoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030350
Enrollment
Unknown
Registered
2020-02-29
Start date
2020-03-10
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic diseases

Interventions

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-55 years; 2. Women who have given birth; 3. Premenopausal women; 3. Preoperative image indicating MCT, unilateral tumor with maximum diameter of 5-10 cm; 4. Without malignant possibilities; 5. AFP within normal range; 6. Patients accept one of the two surgical methods. 7. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Emergency; 2. With history of rectal surgery; 3. With pelvic inflammatory disease, or active lower genital tract infection; 4. Pregnancy; 5. With severe adhesions in operationmalignancy found in operation; 6. With mental illness impairing communication and follow-up; 7. Patients with mental illness affect communication and are difficult to follow up.

Design outcomes

Primary

MeasureTime frame
Operative time;

Secondary

MeasureTime frame
blood loss;spill of tumor content;Intraoperative washing time;time for PORT setting;intraoperative complications;hospital readmission during the first 6 weeks;

Countries

China

Contacts

Public ContactGong Yao

The First Affiliated Hospital of Chongqing Medical University

yao_gong@hotmail.com+86 18623639267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026